Table 3 Change in mean scores on the MMAS-8 between PTA and TAU groups at 16 weeks (intention-to-treat population)

From: Using a smartphone-based self-management platform to support medication adherence and clinical consultation in Parkinson’s disease

Variable

Statistics/category

PTAa

TAUb

All

Morisky Medication Adherence Scale (MMAS-8)

n

68

90

158

 

Mean (SD)

6.30 (1.52)

5.74 (1.53)

5.98 (1.55)

GLM analysisc

Difference and 95%CI

0.39 (0.04,0.74)

  
 

P-value

0.0304

  

Covariate adjusted GLM analysisd

Difference and 95%CI

0.38 (0.03,0.73)

  
 

P-value

0.0331

  
  1. a PTA Parkinson’s tracker app
  2. b Treatment as usual
  3. c GLM generalised linear model
  4. d Age, gender, number of co-morbidities, PD duration were used as covariates. Use of the ©MMAS is protected by US copyright laws. Permission for use is required. A license agreement is available from: Donald E. Morisky, MMAS Research (MORISKY) 14725 NE 20th St. Bellevue, WA 98007; dmorisky@gmail.com
Back to article page